Search

Meet Monika Shah, MD, infectious disease specialist at Memorial Sloan Kettering.

… Friday, April 2, 2021 Monika Shah, MD , infectious disease specialist, Vice Chair of Education in the Department of Medicine, and Chair of Memorial Sloan Kettering’s Graduate Medical Education Committee, is everything you’d want in a good friend. She’s warm, compassionate, and easy to talk to — someone

Memorial Sloan Kettering Cancer Center has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department of Medicine.

… Thursday, September 5, 2013 Memorial Sloan Kettering Cancer Center (MSKCC) has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department

Grief can feel all-consuming, but those intense feelings don’t last forever.

… Wednesday, June 26, 2024 One of life’s most difficult experiences is losing a loved one, and grief doesn’t necessarily follow a straight path through stages that neatly fit into boxes. Though each person’s grief is as unique as their fingerprints, experts have identified some thoughts and feelings common

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.

… Monday, December 16, 2024 Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators. Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan

Pacientes con cáncer de recto vieron cómo sus tumores desaparecían en un ensayo clínico que incluía inmunoterapia en el Memorial Sloan Kettering Cancer Center, sin someterse a cirugía, radiación ni quimioterapia.

… Monday, December 16, 2024 Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators. Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan

The cBioPortal for Cancer Genomics, developed by computational biologists at MSK more than a decade ago, provides valuable data on the genetic makeup of tumors for the broader cancer community.

… Thursday, May 20, 2021 Every month, more than 30,000 scientists from institutions around the world tap into the cBioPortal for Cancer Genomics , which contains data on tens of thousands of tumors. Sharing information to expedite discoveries and improving patient care everywhere have been the key goals

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Jason Lewis, PhD, has been elected as a Fellow of the National Academy of Inventors (NAI), a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the advancement of technology and society.

… Thursday, December 11, 2025 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Jason Lewis, PhD, has been elected as a Fellow of the National Academy of Inventors (NAI) , a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the

Peter T. Meinke will take the Tri-I TDI into the next phase of growth.

… Tuesday, June 12, 2018 Peter T. Meinke, PhD, an accomplished chemist with more than 30 years of industry and academic experience, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI). A pioneering academic-industry collaboration, the Tri-I TDI is designed to expedite

Memorial Sloan Kettering Cancer Center has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research.

… Monday, September 23, 2013 Memorial Sloan Kettering Cancer Center has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research . The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research. The winners are Simon J.

… Wednesday, May 27, 2009 Goals, Milestones, and Transitions Faculty Member Stephen Nimer and First-Year Student Armine Matevossian Faculty Member Stephen Nimer and First-Year Student Armine Matevossian The goal of our graduate program is to increase the pace of translating laboratory findings into clinical